Nanobiotix S.A. (NBTX)Healthcare | Biotechnology | Paris, France | NasdaqGS
39.15 USD
-0.92
(-2.296%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 40.93 +1.78 (4.546%) ⇧ (July 13, 2026, 5:34 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:40 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish due to a lack of clear directional momentum, despite a recent bounce from the lows. While the stock has rallied significantly off its 2022 trough, the underlying business fundamentals remain severely impaired. The company is burning cash aggressively with negative operating cash flow and no revenue generation, while holding a debt load that exceeds its cash reserves. This precarious balance sheet creates a significant overhang that prevents any 'buy' rating, regardless of the potential in its radiotherapy platform. Furthermore, the multi-year price trajectory confirms the market's skepticism; after a massive drop in 2022, the asset has failed to recover, posting declines in both 2024 and 2025. This persistent failure to regain lost ground suggests the market views the current valuation as unjustified given the execution risks and financial strain. Finally, there is no income component to offset these risks, as the company does not distribute any dividends. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.135989 |
| MSTL | 0.137743 |
| AutoTheta | 0.144524 |
| AutoARIMA | 0.195582 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.08 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.038 |
| Excess Kurtosis | 0.13 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.682 |
| Market Cap | 1,988,263,552 |
| Forward P/E | 507.70 |
| Beta | 0.56 |
| Profit Margins | -73.52% |
| Website | https://www.nanobiotix.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 6.7805824 |
| Address1 | 60 rue de Wattignies |
| All Time High | 57.14 |
| All Time Low | 1.75 |
| Ask | 42.36 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 108,650 |
| Average Daily Volume3 Month | 84,988 |
| Average Volume | 84,988 |
| Average Volume10Days | 108,650 |
| Beta | 0.56 |
| Bid | 39.0 |
| Bid Size | 2 |
| Book Value | -1.990632 |
| City | Paris |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | France |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 39.15 |
| Current Ratio | 1.091 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 40.52 |
| Day Low | 38.7401 |
| Display Name | Nanobiotix |
| Earnings Call Timestamp End | 1,775,044,800 |
| Earnings Call Timestamp Start | 1,775,044,800 |
| Earnings Timestamp End | 1,774,987,200 |
| Earnings Timestamp Start | 1,774,987,200 |
| Ebitda | -10,489,000 |
| Ebitda Margins | -0.32182 |
| Enterprise To Ebitda | -184.666 |
| Enterprise To Revenue | 59.429 |
| Enterprise Value | 1,936,957,184 |
| Eps Current Year | 0.04253 |
| Eps Forward | 0.077113174 |
| Eps Trailing Twelve Months | -0.57 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 39.3888 |
| Fifty Day Average Change | -0.23880005 |
| Fifty Day Average Change Percent | -0.006062638 |
| Fifty Two Week Change Percent | 678.0582 |
| Fifty Two Week High | 57.14 |
| Fifty Two Week High Change | -17.989998 |
| Fifty Two Week High Change Percent | -0.3148407 |
| Fifty Two Week Low | 4.93 |
| Fifty Two Week Low Change | 34.22 |
| Fifty Two Week Low Change Percent | 6.941177 |
| Fifty Two Week Range | 4.93 - 57.14 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,607,697,000,000 |
| Float Shares | 31,824,271 |
| Forward Eps | 0.077113174 |
| Forward P E | 507.69537 |
| Free Cashflow | -7,894,125 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 100 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 32,593,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.11755 |
| Implied Shares Outstanding | 50,785,785 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-12-11 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. |
| Long Name | Nanobiotix S.A. |
| Market | us_market |
| Market Cap | 1,988,263,552 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_20950715 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -23,961,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,056,608,076 |
| Number Of Analyst Opinions | 5 |
| Open | 39.95 |
| Operating Cashflow | -33,422,000 |
| Operating Margins | -1.9642301 |
| Payout Ratio | 0.0 |
| Phone | 33 1 40 26 04 70 |
| Post Market Change | 1.7795982 |
| Post Market Change Percent | 4.545589 |
| Post Market Price | 40.9296 |
| Post Market Time | 1,783,978,486 |
| Previous Close | 40.07 |
| Price Eps Current Year | 920.52673 |
| Price Hint | 2 |
| Price To Book | -19.667122 |
| Price To Sales Trailing12 Months | 61.002777 |
| Profit Margins | -0.73516 |
| Quick Ratio | 1.051 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.28571 |
| Region | US |
| Regular Market Change | -0.919998 |
| Regular Market Change Percent | -2.29598 |
| Regular Market Day High | 40.52 |
| Regular Market Day Low | 38.7401 |
| Regular Market Day Range | 38.7401 - 40.52 |
| Regular Market Open | 39.95 |
| Regular Market Previous Close | 40.07 |
| Regular Market Price | 39.15 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 106,628 |
| Return On Assets | -0.10063 |
| Revenue Per Share | 0.682 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 50,785,785 |
| Shares Percent Shares Out | 0.001 |
| Shares Short | 52,503 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 33,421 |
| Short Name | Nanobiotix S.A. |
| Short Percent Of Float | 0.0014 |
| Short Ratio | 0.69 |
| Source Interval | 15 |
| Symbol | NBTX |
| Target High Price | 68.82775 |
| Target Low Price | 29.141033 |
| Target Mean Price | 48.445885 |
| Target Median Price | 45.14582 |
| Total Cash | 52,750,000 |
| Total Cash Per Share | 1.09 |
| Total Debt | 95,319,000 |
| Total Revenue | 32,593,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.57 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 28.428354 |
| Two Hundred Day Average Change | 10.721647 |
| Two Hundred Day Average Change Percent | 0.37714624 |
| Type Disp | Equity |
| Volume | 106,628 |
| Website | https://www.nanobiotix.com |
| Zip | 75,012 |